Ask us your question


Need help?

Gemma coasts to a heart-felt challenge

6th June 2016

LEEK United Customer Adviser Gemma Callear is coasting towards a marathon cycle journey right across Britain in aid of a charity close to her heart.

She plans to pedal 150 miles coast-to-coast in the North of England next month (June) to raise money in memory of her uncle, Charlie Talks.

Charlie, who lived in Leek, died in late 2014 after suffering from a brain tumour.

And mum of two and step-mum of three Gemma’s poignant journey will benefit North Staffordshire-based Lucas’ Legacy*, a charity dedicated to funding research into childhood brain tumours.

Gemma and husband Steve will cycle from the seaside town of Whitehaven in Cumbria to Hartlepool on the North-East coast in three days, covering the cost of overnight B&B accommodation en route themselves.

“The story of Lucas and the charity set up in his name really touched us both – I was in tears before I had even finished reading it,” said Gemma, who works at Leek United’s Derby Street Branch in Leek.

“Our youngest son, Ashton, is seven – the same age that Lucas would have been. Lucas’ family are doing an amazing job raising money for research into childhood brain tumours – this year alone, they have raised £50,000 – so we got in touch with them to see what we
could do to help.”

Accompanying Gemma and Steve on their coast-to-coast journey will be Ashton and Gemma’s mother-in-law, Rose Callear, in a back-up vehicle.

Added Gemma: “It won’t be an easy trip; the first two days are through the Lake District – mostly uphill! – and until six months ago, I didn’t even own a bike, but I’ve been putting in the practise miles and am ready for the challenge.”

Gemma’s coast-to-coast trip starts on 24th June, and she has a JustGiving page for anyone wishing to donate.

*Lucas Williams, of Stoke-on-Trent, died in August 2015, just 11 weeks after becoming ill.  Lucas’ Legacy was set up by his parents, Jo and Andrew, with the aim of raising £50,000 for research into childhood brain tumours.

Back to news